Chemoradiation for carcinoma of the cervix: Advances and opportunities

Radiation Research

Volumn 154, Issue 3, 2000, Pages 229-236

  Eifel, P J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN DERIVATIVE; CARBOPLATIN; CISPLATIN; FLUOROURACIL; MITOMYCIN C; TAXANE DERIVATIVE; TIRAPAZAMINE;

CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RECURRENCE; CANCER SURVIVAL; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX CARCINOMA;

EID: 0033818445     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2000)154[0229:CFCOTC]2.0.CO;2     Document Type: Review

References (49)

1. Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer
2. Cisplatin, 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive therapy in high-risk, early-stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy. Report of a Phase III Intergroup Study
3. Concurrent cisplatin-based chemotherapy and radiotherapy for locally advanced cervical cancer
4. Cisplatin, radiation, and adjuvant hysterectomy for bulky stage IB cervical carcinoma
5. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study
6. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix
7. FIGO stage IIIB squamous cell carcinoma of the uterine cervix: An analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy
8. High dose-rate brachytherapy for carcinoma of the cervix: High tech or high risk?
9. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: Analysis of tumor recurrence - The University of Wisconsin experience
10. Cisplatin in advanced cancer of the cervix: An update
11. Essai randomise de chimiotherapie initiale dans 151 carcinomes du col uterin localement etendus (T2b-N1, T3b, MO)
12. Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: A randomized study
13. Induction chemotherapy and radiotherapy of advanced cancer of the cervix: A pilot study and phase III randomized trial
14. A randomized trial of chemotherapy followed by pelvic radiation therapy in Stage IIIB carcinoma of the cervix
15. Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A
16. Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer
17. A randomized trial comparing platinum-based chemotherapy followed by radiotherapy vs. radiotherapy alone in patients with locally advanced cervical cancer
18. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: The final results
19. Meta-analyses in head and neck squamous cell carcinoma. What is the role of chemotherapy?
20. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials
21. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer
22. Adjuvant chemotherapy for head and neck cancer
23. Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): Analysis of Radiation Therapy Oncology-Group (RTOG) trials
24. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group
25. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and Chemotherapy: Initial results of Radiation Therapy Oncology Group 89-03
26. Repair of potentially lethal damage in x-irradiated HeLa cells
27. Effect of hydroxyurea on the radiation response of C3H mouse mammary tumors
28. The combined effect of hydroxyurea and x-rays on Chinese hamster cells in vitro
29. Hydroxyurea and radiation therapy in advanced cervical cancer
30. Effect of cis-dichlorodiammine platinum II and X rays on mammalian cell survival
31. Schedule-dependent therapeutic gain from the combination of fractionated irradiation plus c-DDP and 5-FU or plus c-DDP and cyclophosphamide in C3H/ Km mouse model systems
32. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and x-rays
33. Mechanisms of action and modulation of fluorouracil
34. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery
35. A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study
36. Radiotherapy with or without misonidazole for patients with stage IIIB or IVA squamous cell carcinoma of the uterine cervix: Preliminary report of a Radiation Therapy Oncology Group randomized trial
37. Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervix
38. Hydroxyurea versus misonidazole with radiation in cervical carcinoma: Long-term follow-up of a Gynecologic Oncology Group trial
39. New standard of care for cervical cancer sets stage for next questions
40. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20
41. Long-term follow-up of potentiation of radiotherapy by cis-platinum in advanced cervical cancer
42. Mature results of a pilot study of pelvic radiotherapy with concurrent continuous infusion intra-arterial 5-FU for stage IIIB-IVA squamous cell carcinoma of the cervix
43. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer
44. Anal canal carcinomas
45. Concurrent 5-fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer
46. Concomitant pelvic irradiation, 5-fluorouracil and mitomycin C in the treatment of advanced cervical carcinoma
47. Concurrent radiation therapy, cis-platinum, and mitomycin C in patients with poor prognosis cancer of the cervix: A pilot study
48. Role of mitomycin C in the development of late bowel toxicity following chemoradiation for locally advanced carcinoma of the cervix
49. Concurrent chemoradiation in advanced cervical cancer